AHCO
AdaptHealth·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Consensus Rating "Strong Buy"
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AHCO
Adapthealth Corp.
A national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services
Healthcare Providers and Services
11/22/2017
06/12/2018
NASDAQ Stock Exchange
10,500
12-31
Common stock
555 East North Lane, Suite 5075, Conshohocken, Pennsylvania 19428
--
AdaptHealth Corp. was incorporated as a Delaware corporation on November 22, 2017. The company is a national leader in providing patient-centered and technology-enabled chronic disease management solutions, including home health equipment, home medical supplies and related services in the United States. The Company is primarily focused on providing individuals with obstructive sleep apnea (" OSA ") with (i) sleep therapy equipment, supplies and related services, including CPAP and bi PAP services, (ii) medical equipment and diabetes supplies for treatment, including continuous glucose monitors (" CGM ") and insulin pumps, (iii) home medical devices (" HME "), For patients discharged from acute care and other facilities, (iv) in-home oxygen and related chronic treatment services, and (v) other HME medical equipment and supplies representing chronically ill patients with wound care, urology, incontinence, ostomy and nutritional supply needs. The company serves beneficiaries of Medicare, Medicaid and commercial payers.
Earnings Call
Q1/2025
Estimate EPS0.04
Actual EPS-0.05
Estimate Revenue764.77M
Actual Revenue777.88M
AdaptHealth's Q1 2025 Earnings Call: Navigating Contradictions in Divestitures, Market Dynamics, and Segment Performance
May 06,2025 04:01
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.16
Actual EPS0.1
Estimate Revenue803.80M
Actual Revenue800.40M
AdaptHealth's Q2 2025: Unpacking Contradictions in Sleep Market, Diabetes Performance, and Divestiture Strategy
Aug 05,2025 11:15
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
AHCO has released its 2025 Q3 earnings. EPS was reported at 0.16, versus the expected 0.24, missing expectations. The chart below visualizes how AHCO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
AHCO has released its 2025 Q3 earnings report, with revenue of 820.31M, reflecting a YoY change of 1.79%, and net profit of 25.75M, showing a YoY change of 7.49%. The Sankey diagram below clearly presents AHCO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
